Condition

Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (3)

Accelerated Phase Chronic Myelogenous Leukemia (1)

Blastic Phase Chronic Myelogenous Leukemia (1)

Chronic Myelogenous Leukemia (1)

Chronic Myeloid Leukemia (1)

Chronic Phase Chronic Myelogenous Leukemia (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Incyte Biosciences UK (1)

Korea Otsuka Pharmaceutical Co., Ltd. (1)

Novartis Pharmaceuticals (1)

Collaborator

Intervention

abl001 (1)

abl001 + nilotinib (1)

abl001+dasatinib (1)

abl001+imatinib (1)

ponatinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (3)

Study Type

Observational (2)

Interventional (1)

Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting

Chronic Myelogenous Leukemia
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

ABL001
+3 more

Boston, Massachusetts
+18 more

Jan 19, 2023

Iclusig PMS in CML or Ph+ALL Patients

Recruiting

Chronic Myeloid Leukemia
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Ponatinib

Busan, Korea, Republic of

Kosin University Gaspel Hospital

Sep 16, 2021

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Completed

Chronic Phase Chronic Myelogenous Leukemia
+3 more

Limerick, Dooradoyle, Ireland
+32 more

Aug 13, 2021